Olfactomedin-4 and Nanog homeobox were positive and negative predictive factors, respectively, for eradication therapy efficacy against gastric MALT lymphoma; they were negative for both API2-MALT1 and Hp. The gene discussed is OLFM4; the disease is gastric mucosa-associated lymphoid tissue lymphoma.